481 related articles for article (PubMed ID: 15064752)
21. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
22. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells.
Su L; Mukherjee AB; Mukherjee BB
Oncogene; 1995 Jun; 10(11):2163-9. PubMed ID: 7784060
[TBL] [Abstract][Full Text] [Related]
23. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
24. c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation.
Watts RG; Ben-Ari ET; Bernstein LR; Birrer MJ; Winterstein D; Wendel E; Colburn NH
Mol Carcinog; 1995 May; 13(1):27-36. PubMed ID: 7766308
[TBL] [Abstract][Full Text] [Related]
25. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes.
Dong Z; Crawford HC; Lavrovsky V; Taub D; Watts R; Matrisian LM; Colburn NH
Mol Carcinog; 1997 Jul; 19(3):204-12. PubMed ID: 9254887
[TBL] [Abstract][Full Text] [Related]
26. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect on activator protein-1, nuclear factor-kappaB, and cell transformation by extracts of strawberries (Fragaria x ananassa Duch.).
Wang SY; Feng R; Lu Y; Bowman L; Ding M
J Agric Food Chem; 2005 May; 53(10):4187-93. PubMed ID: 15884858
[TBL] [Abstract][Full Text] [Related]
28. Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor kappaB transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells.
Liu R; O'Connell M; Johnson K; Pritzker K; Mackman N; Terkeltaub R
Arthritis Rheum; 2000 May; 43(5):1145-55. PubMed ID: 10817569
[TBL] [Abstract][Full Text] [Related]
29. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade.
Song MS; Park YK; Lee JH; Park K
Cancer Res; 2001 Nov; 61(22):8322-30. PubMed ID: 11719466
[TBL] [Abstract][Full Text] [Related]
30. p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells.
Leaner VD; Donninger H; Ellis CA; Clark GJ; Birrer MJ
Mol Cell Biol; 2005 Apr; 25(8):3324-37. PubMed ID: 15798216
[TBL] [Abstract][Full Text] [Related]
31. Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes.
Li JJ; Cao Y; Young MR; Colburn NH
Mol Carcinog; 2000 Nov; 29(3):159-69. PubMed ID: 11108661
[TBL] [Abstract][Full Text] [Related]
32. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
Yu W; Simmons-Menchaca M; You H; Brown P; Birrer MJ; Sanders BG; Kline K
Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
[TBL] [Abstract][Full Text] [Related]
33. Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice.
Domann FE; Levy JP; Birrer MJ; Bowden GT
Cell Growth Differ; 1994 Jan; 5(1):9-16. PubMed ID: 8123597
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of atypical PKC blocks ultraviolet-induced AP-1 activation by specifically inhibiting ERKs activation.
Huang C; Li J; Chen N; Ma W; Bowden GT; Dong Z
Mol Carcinog; 2000 Feb; 27(2):65-75. PubMed ID: 10657899
[TBL] [Abstract][Full Text] [Related]
35. Differential inhibition of UVB-induced AP-1 and NF-kappaB transactivation by components of the jun bZIP domain.
Cooper S; Ranger-Moore J; Bowden TG
Mol Carcinog; 2005 Jun; 43(2):108-16. PubMed ID: 15791649
[TBL] [Abstract][Full Text] [Related]
36. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis.
Hsu TC; Young MR; Cmarik J; Colburn NH
Free Radic Biol Med; 2000 May; 28(9):1338-48. PubMed ID: 10924853
[TBL] [Abstract][Full Text] [Related]
37. bcl-2 enhancement of malignant transformation in mouse epidermal JB6 cells.
Amstad PA; Liu H; Ichimiya M; Chang S; Berezesky IK; Trump BF
Mol Carcinog; 1997 Oct; 20(2):231-9. PubMed ID: 9364213
[TBL] [Abstract][Full Text] [Related]
38. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
Dong Z; Birrer MJ; Watts RG; Matrisian LM; Colburn NH
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):609-13. PubMed ID: 8290571
[TBL] [Abstract][Full Text] [Related]
39. Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway.
Arnott CH; Scott KA; Moore RJ; Hewer A; Phillips DH; Parker P; Balkwill FR; Owens DM
Oncogene; 2002 Jul; 21(31):4728-38. PubMed ID: 12101411
[TBL] [Abstract][Full Text] [Related]
40. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
